Main > ONCOLOGY (**) > Leukemia>Lymphoblastic>Acute>Ph+*** > Treatment > Co.: USA. A. Ponatinib

---

Co.: USA. A. Ponatinib's subsections
Approved in: AU, CA, CH, EU, IL, US
Approved in: JP
Company/Licensor
Licensee in CH, EU, IL & RU:
Mechanism: BCR-ABL inhibitor
TradeMark
TradeMark Web-Site (USA)
UpDate: 2016. 09.28.

Co.: USA. A. Ponatinib's products
This section has no products